The biopharmaceutical industry currently enjoys an expanding world of opportunity and has come up with many business models to serve global healthcare. Different product portfolios — from proteins to cell/gene therapies, vaccines to biosimilars — often require different business strategies. International markets require paying attention to different regulations, cultures, and infrastructure. Challenges remain, but optimism reigns. Authors, reader-survey respondents, and editorial advisors will help us examine trends in investment and finance, marketing/pricing and business development, outsourcing and legal issues, recruitment and training, partnering, product portfolios, and more.

Get the eBook Now